The test enables precise detection of a range of complex genomic alterations that are features of many rare diseases and undetectable by traditional approaches
Researchers at St. Jude Children’s Research Hospital have created a cost-effective, easy-to-use test to categorize a child’s cancer and guide better treatment
“Jaw dropping” findings suggest there are yet undiscovered mechanisms for telomere length regulation, offering hope for treating cancer and degenerative disease
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.